欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号PT/H/2244/001
药品名称Gemcit
活性成分
    • gemcitabine hydrochloride 38.0 mg/ml
剂型Powder for solution for infusion
上市许可持有人Fresenius Kabi Pharma Portugal, Lda.
参考成员国 - 产品名称Portugal (PT)
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 08828/0219 - 0026
    • Germany (DE)
    • Norway (NO)
    • Lithuania (LT)
      Gemcit 38mg/ml milteliai infuziniam tirpalui
    • Romania (RO)
      Gemcirena 38 mg/ml, pulbere pentru soluţie perfuzabilă
许可日期2009/01/07
最近更新日期2024/08/13
药物ATC编码
    • L01BC05 gemcitabine
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase